2019-06-06 |
2019-06-04 |
PS
Planned sale
|
Sandor Victor
Chief Medical Officer
|
100,000
-32.3%
28.51
USD 2,851,000
|
100,000
-32.3%
|
28.51
|
USD 2,851,000
|
|
2019-06-03 |
2019-06-03 |
PS
Planned sale
|
Sandor Victor
Chief Medical Officer
|
36,134
-14.7%
27.58
USD 996,738
|
36,134
-14.7%
|
27.58
|
USD 996,738
|
|
2019-06-03 |
2019-05-30 |
PS
Planned sale
|
Sandor Victor
Chief Medical Officer
|
15,728
-7.0%
27.50
USD 432,520
|
15,728
-7.0%
|
27.50
|
USD 432,520
|
|
2019-05-28 |
2019-05-28 |
PS
Planned sale
|
Sandor Victor
Chief Medical Officer
|
74,915
-26.3%
27.00
USD 2,022,930
|
74,915
-26.3%
|
27.00
|
USD 2,022,930
|
|
2019-05-28 |
2019-05-23 |
PS
Planned sale
|
Sandor Victor
Chief Medical Officer
|
40,634
-14.6%
26.50
USD 1,076,846
|
40,634
-14.6%
|
26.50
|
USD 1,076,846
|
|
2019-05-23 |
2019-05-21 |
PS
Planned sale
|
Sandor Victor
Chief Medical Officer
|
12,600
-5.0%
26.50
USD 333,900
|
12,600
-5.0%
|
26.50
|
USD 333,900
|
|
2019-02-21 |
2019-02-19 |
B
Purchase
|
COX CARRIE SMITH
|
5,000
+166.7%
23.20
USD 115,998
|
5,000
+166.7%
|
23.20
|
USD 115,998
|
|
2019-02-08 |
2019-02-07 |
PS
Planned sale
|
Haddock Jason
CFO
|
85,000
-73.9%
22.05
USD 1,874,301
|
85,000
-73.9%
|
22.05
|
USD 1,874,301
|
|
2019-02-08 |
2019-02-07 |
PS
Planned sale
|
Squarer Ron
CEO
|
110,000
-31.5%
21.64
USD 2,380,015
|
110,000
-31.5%
|
21.64
|
USD 2,380,015
|
|
2019-02-08 |
2019-02-07 |
PS
Planned sale
|
Saccomano Nicholas A
CSO
|
187,264
-56.8%
21.58
USD 4,041,756
|
187,264
-56.8%
|
21.58
|
USD 4,041,756
|
|
2019-02-08 |
2019-02-06 |
PS
Planned sale
|
Haddock Jason
CFO
|
11,712
-28.0%
20.00
USD 234,240
|
11,712
-28.0%
|
20.00
|
USD 234,240
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
LEFKOFF KYLE
|
5,000
-20.0%
20.85
USD 104,261
|
5,000
-20.0%
|
20.85
|
USD 104,261
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
LEFKOFF KYLE
|
5,000
-16.7%
20.82
USD 104,121
|
5,000
-16.7%
|
20.82
|
USD 104,121
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
LEFKOFF KYLE
|
25,000
-52.4%
20.51
USD 512,693
|
25,000
-52.4%
|
20.51
|
USD 512,693
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
Robbins Andrew R
COO
|
239,626
-80.0%
20.03
USD 4,798,511
|
239,626
-80.0%
|
20.03
|
USD 4,798,511
|
|
2019-02-07 |
2019-02-05 |
PS
Planned sale
|
Oltmans Curtis Gale
General Counsel
|
40,000
-72.7%
20.00
USD 800,000
|
40,000
-72.7%
|
20.00
|
USD 800,000
|
|
2019-02-01 |
2019-01-31 |
PS
Planned sale
|
Squarer Ron
CEO
|
113,438
-32.2%
18.53
USD 2,101,541
|
113,438
-32.2%
|
18.53
|
USD 2,101,541
|
|
2019-02-01 |
2019-01-30 |
PS
Planned sale
|
Squarer Ron
CEO
|
100,000
-29.5%
18.25
USD 1,825,370
|
100,000
-29.5%
|
18.25
|
USD 1,825,370
|
|
2019-01-29 |
2019-01-25 |
PS
Planned sale
|
Oltmans Curtis Gale
General Counsel
|
14,029
-78.2%
18.00
USD 252,523
|
14,029
-78.2%
|
18.00
|
USD 252,523
|
|
2019-01-23 |
2019-01-18 |
PS
Planned sale
|
Oltmans Curtis Gale
General Counsel
|
1,251
-24.2%
18.00
USD 22,518
|
1,251
-24.2%
|
18.00
|
USD 22,518
|
|